Skip to main content

Table 3 Performance evaluation for Alzheimer’s disease

From: Mining biomarker information in biomedical literature

Selection

Rank

Recall

Precision

F-score

Baseline: Genes / Proteins

60

0.10

0.92

0.17

 

230

0.30

0.73

0.42

 

469

0.50

0.61

0.55

Maximal F-score

728

0.67

0.52

0.59

Baseline + Clinical Management

61

0.10

0.90

0.17

 

226

0.30

0.75

0.42

 

465

0.50

0.61

0.55

Maximal F-score

682

0.65

0.54

0.59

Baseline + Evidence Marker

62

0.10

0.89

0.17

 

225

0.30

0.75

0.42

 

464

0.50

0.61

0.55

Maximal F-score

654

0.62

0.54

0.57

Baseline +Prognosis

63

0.10

0.87

0.17

 

247

0.30

0.68

0.41

 

541

0.50

0.52

0.51

Maximal F-score

740

0.61

0.47

0.53

Baseline + Diagnostics

64

0.10

0.86

0.17

 

237

0.30

0.71

0.42

 

494

0.50

0.57

0.53

Maximal F-score

520

0.52

0.57

0.54

Baseline + Statistics

64

0.10

0.86

0.17

 

227

0.30

0.74

0.42

 

678

0.50

0.42

0.45

Maximal F-score

377

0.41

0.62

0.49

Baseline + Clinical Management + Evidence Marker

60

0.10

0.92

0.17

 

224

0.30

0.75

0.42

 

451

0.50

0.63

0.56

Maximal F-score

555

0.57

0.59

0.58

Baseline + Clinical Management + Evidence Marker + Prognosis

61

0.10

0.90

0.17

 

230

0.30

0.73

0.42

 

568

0.50

0.50

0.50

Maximal F-score

479

0.47

0.56

0.51

  1. Genes were ranked based on frequency and evaluated against the Alzheimer’s gold standard. For the different selections recall, precision, F-score and rank has been estimated for 10, 30, and 50% recall. In addition the maximal recall has been estimated.